JRJessica E. Rexach

Jessica E. Rexach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jessica E. Rexach has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel H. Geschwind

    Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA

    3 shared publications
  • Ashvin Ravi

    Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    2 shared publications
  • Lea T. Grinberg

    Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA

    2 shared publications
  • Salvatore Spina

    Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA

    2 shared publications
  • Tao Zhang

    Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA

    2 shared publications
  • William W. Seeley

    Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA

    2 shared publications

Latest Publications

  • Open Access

    Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states

    by Xia Han, Gregory M. Rosenberg, Vivianne M. Kisling, Tao Zhang, Chia-Yi Lee, Ashvin Ravi, Mikhail Melnik, Tina Bilousova, Salvatore Spina, Alissa L. Nana, et al.

    The accumulation of abnormal tau protein selectively affects distinct brain regions and specific populations of neurons and glial cells in tau-related dementias, such as Alzheimer’s disease, Pick’s disease and progressive supranuclear palsy. Although the three disorders share the feature of tau protein pathology, the regulatory circuitry of non-coding genetic variants underlying risk-associated cell states remains to be elucidated. Using paired single-nucleus profiling of chromatin accessibility and gene expression across the three conditions, we define cell-type-specific cis-regulatory elements across six cell types and fifty subclasses. Comparing disease-dynamic cis-regulatory elements across three disorders, we find that glia overrepresent disorder-specific gene regulation related to dynamic cellular response to stress. We show that human genetic variants affecting microglial gene regulation converge into distinct and co-regulated modules affecting specific cellular functions. Moreover, polygenic risk modifiers are maximally co-accessible in disorder-specific glial states, modifying distinct pathways such as sphingomyelin regulation in Pick’s disease. Our study informs glial regulators linked to polygenic modifiers of primary tauopathy, establishing modifiable pathways governing resilience.


  • Open Access

    Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states

    by Xia Han, Tao Zhang, Chia-Yi Lee, Ashvin Ravi, Salvatore Spina, Alissa Nana Li, Lea T. Grinberg, William W. Seeley, Laura M. Huckins, Towfique Raj, et al.

    The accumulation of abnormal tau protein selectively affects distinct brain regions and specific populations of neurons and glial cells in tau-related dementias, such as Alzheimer’s disease (AD), Pick’s disease (PiD), and progressive supranuclear palsy (PSP). Although the three disorders share the feature of tau protein pathology, the regulatory circuitry of non-coding genetic variants underlying risk-associated cell states remains to be elucidated. Using paired single-nucleus profiling of chromatin accessibility and gene expression across AD, PiD, and PSP, we define cell-type-specific cis-regulatory elements (CREs) across six cell types and fifty subclasses. Comparing disease-dynamic CREs across three disorders, we find that glia overrepresent disorder-specific gene regulation related to dynamic cellular response to stress. We show that human genetic variants affecting microglial gene regulation converge into distinct and co-regulated modules affecting specific cellular functions. Moreover, polygenic risk modifiers are maximally co-accessible in disorder-specific glial states, modifying distinct pathways such as sphingomyelin regulation in PiD. Our study informs glial regulators linked to polygenic modifiers of primary tauopathy, introducing modifiable pathways governing resilience for therapeutic consideration.

  • Open Access

    Dynamic disease‐associated gene regulatory transitions unmask genetic risk associated neurodegenerative cell states

    by Xia Han, Jessica E Rexach

    Background: Abnormal tau protein accumulation selectively affects distinct brain regions and specific neuron and glia populations in tau‐related dementias like Alzheimer’s disease (AD), frontotemporal dementia (FTD, Pick’s disease type), and Progressive supranuclear palsy (PSP). The regulatory mechanisms governing cell‐type vulnerability remain unclear.Method: In a cross‐disorder single‐nucleus analysis, we examined 663,896 nuclei, assessing chromatin accessibility in three brain regions (motor cortex, visual cortex and insular cortex) across PSP, AD, and FTD in 40 individuals. Integrating genetic data with single‐nucleus RNA sequencing, we identified cell‐type‐specific cis‐regulatory elements (CREs) influencing disease‐associated transcriptional changes. Connecting GWAS signals to cell types enabled precise mapping of risk‐associated genetic elements to disorder‐specific gene regulatory events, accounting for dynamic gene regulation in the diseased brain.Result: Disorder enriched CRE modules were primarily activated in PSP astrocytes and FTD microglia. PSP exhibited increased astrocyte involvement, identified by distinct changes in astrocytes (ast.C1). In contrast, FTD featured microglia with suppressed GRN expression (mg.C4). Differentially accessible gene regulatory elements in mg.C4 uniquely and significantly contributed to FTD risk heritability across microglia. Disease dynamic chromatin accessibility peaks and gene enhancer elements, especially in astrocytes, accounted for more AD and PSP heritability, while FTD heritability predominantly involved microglial upregulated peaks.Conclusion: This study enhances our understanding of disease heritability, reinforcing the multicellular model of neurodegeneration. Glial cell types interacting with disease‐specific elements form disorder‐specific networks, deepening knowledge of genomic and cellular mechanisms in tau‐associated neurodegeneration.

  • Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics

    by Jessica E. Rexach, Yuyan Cheng, Lawrence Chen, Damon Polioudakis, Li-Chun Lin, Vivianne Mitri, Andrew Elkins, Xia Han, Mai Yamakawa, Anna Yin, et al.


  • Open Access

    Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer’s Disease

    by Mai Yamakawa, Jessica E. Rexach

    Alzheimer’s disease (AD) is a multi-stage neurodegenerative disorder characterized by beta-amyloid accumulation, hyperphosphorylated Tau deposits, neurodegeneration, neuroinflammation, and cognitive impairment. Recent studies implicate CD8 T cells as neuroimmune responders to the accumulation of AD pathology in the brain and potential contributors to toxic neuroinflammation. However, more evidence is needed to understand lymphocytes in disease, including their functional states, molecular mediators, and interacting cell types in diseased brain tissue. The scarcity of lymphocytes in brain tissue samples has limited the unbiased profiling of disease-associated cell types, cell states, drug targets, and relationships to common AD genetic risk variants based on transcriptomic analyses. However, using recent large-scale, high-quality single-nuclear sequencing datasets from over 84 Alzheimer’s disease and control cases, we leverage single-nuclear RNAseq data from 800 lymphocytes collected from 70 individuals to complete unbiased molecular profiling. We demonstrate that effector memory CD8 T cells are the major lymphocyte subclass enriched in the brain tissues of individuals with AD dementia. We define disease-enriched interactions involving CD8 T cells and multiple brain cell subclasses including two distinct microglial disease states that correlate, respectively, to beta-amyloid and tau pathology. We find that beta-amyloid-associated microglia are a major hub of multicellular cross-talk gained in disease, including interactions involving both vulnerable neuronal subtypes and CD8 T cells. We reproduce prior reports that amyloid-response microglia are depleted in APOE4 carriers. Overall, these human-based studies provide additional support for the potential relevance of effector memory CD8 T cells as a lymphocyte population of interest in AD dementia and provide new candidate interacting partners and drug targets for further functional study.


  • Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults.

    by Cutter A. Lindbergh, Hillblom Aging Network, Kaitlin B. Casaletto, Adam M. Staffaroni, Renaud La Joie, Leonardo Iaccarino, Lauren Edwards, Elena Tsoy, Fanny Elahi, Samantha M. Walters, et al.

    Objective: We aimed to test the hypothesis that elevated neocortical β-amyloid (Aβ), a hallmark feature of Alzheimer's disease (AD), predicts sex-specific cognitive trajectories in clinically normal older adults, with women showing greater risk of decline than men. Method: Florbetapir Aβ positron emission tomography (PET) was acquired in 149 clinically normal older adults (52% female, Mage = 74). Participants underwent cognitive testing at baseline and during annual follow-up visits over a timespan of up to 5.14 years. Mixed-effects regression models evaluated whether relations between baseline neocortical Standardized Uptake Value Ratio (SUVR) and composite scores of episodic memory, executive functioning, and processing speed were moderated by sex (male/female) and apolipoprotein E (APOE) status (ε4 carrier/noncarrier). Results: Higher baseline SUVR was associated with longitudinal decline in episodic memory in women (b = -1.32, p < .001) but not men (b = -0.30, p = .28). Female APOE ε4 carriers with elevated SUVR showed particularly precipitous declines in episodic memory (b = -4.33, p < .001) whereas other cognitive domains were spared. SUVR did not predict changes in executive functioning or processing speed, regardless of sex (ps >.63), though there was a main effect of SUVR on processing speed (b = 2.50, p = .003). Conclusions: Clinically normal women with elevated Aβ are more vulnerable to episodic memory decline than men. Understanding sex-related differences in AD, particularly in preclinical stages, is crucial for guiding precision medicine approaches to early detection and intervention. (PsycInfo Database Record (c) 2020 APA, all rights reserved).


  • Open Access

    Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes

    by Jiwen Li, Lin Pan, Marlesa I. Godoy, William G. Pembroke, Jessica E. Rexach, Michael C. Condro, Alvaro G. Alvarado, Mineli Harteni, Yen-Wei Chen, Linsey Stiles, et al.

    Summary: Human-mouse differences are a major barrier in translational research. Astrocytes play important roles in neurological disorders such as stroke, injury, and neurodegeneration. However, the similarities and differences between human and mouse astrocytes are largely unknown. Combining analyses of acutely purified astrocytes, experiments using serum-free cultures of primary astrocytes, and xenografted chimeric mice, we found extensive conservation in astrocytic gene expression between human and mouse. However, genes involved in defense response and metabolism showed species differences. Human astrocytes exhibited greater susceptibility to oxidative stress than mouse astrocytes, due to differences in mitochondria physiology and detoxification pathways. Mouse astrocytes, but not human astrocytes, activate a molecular program for neural repair under hypoxia. Human astrocytes, but not mouse astrocytes, activate the antigen presentation pathway under inflammatory conditions. These species-dependent properties of astrocytes may contribute to differences between mouse models and human neurological and psychiatric disorders.


  • Open Access

    Dementia risk genes engage gene networks poised to tune the immune response towards chronic inflammatory states

    by Jessica Rexach, Vivek Swarup, Timothy S Chang, Daniel H Geschwind

    An emerging challenge in neurodegenerative dementia is understanding how immune-associated genes and pathways contribute to disease. To achieve a refined view of neuroinflammatory signaling across neurodegeneration, we took an integrative functional genomics approach to consider neurodegeneration from the perspective of microglia and their interactions with other cells. Using large-scale gene expression and perturbation data, regulatory motif analysis, and gene knockout studies, we identify and characterize a microglial-centric network involving distinct gene co-expression modules associated with progressive stages of neurodegeneration. These modules, which are conserved from mouse to human, differentially incorporate specific immune sensors of cellular damage and pathways that are predicted to eventually tune the immune response toward chronic inflammation and immune suppression. Notably, common genetic risk for Alzheimer’s disease (AD), Frontotemporal dementia (FTD) and Progressive Supranuclear Palsy (PSP) resides in specific modules that distinguish between the disorders, but also show convergence on pathways related to anti-viral defense mechanisms. These results suggest a model wherein combinatorial microglial-immune signaling integrate specific immune activators and disease genes that lead to the establishment of chronic states of simultaneous inflammation and immunosuppression involving type 1 interferon in these dementias.